Skip to content

Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram

Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04929574
Enrollment
1200
Registered
2021-06-18
Start date
2021-07-01
Completion date
2025-12-30
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta Thalassemia

Brief summary

Heart failure from myocardial iron deposition is a severe complication for patients with transfusion-dependent beta thalassemia . Increased cardiac iron content impacts the contractility of cardiomyocytes and can also lead to myocarditis, pericarditis, and arrhythmias. The severity of cardiac dysfunction depends on the amount of iron deposited in the myocardium.Echocardiogram is used as noninvasive method to observe heart status. The objective of this study is to evaluate the heart status in patients of Beta Thalassemia from southern China.

Interventions

DIAGNOSTIC_TESTEchocardiogram and Hematological Analysis

Echocardiogram and Hematological Analysis

Sponsors

ZhuHai Hospital
CollaboratorOTHER
Shenzhen Children's Hospital
CollaboratorOTHER_GOV
Shenzhen Second People's Hospital
CollaboratorOTHER
Jiangmen Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
Yongzhou Maternity and Child Health Hospital
CollaboratorUNKNOWN
Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Diagnosed with beta-thalassemia

Exclusion criteria

* Iron deficiency anemia

Design outcomes

Primary

MeasureTime frameDescription
Echocardiogram3 yearsEvaluation of heart function in beta thalassemia patients by left ventricular fraction shortening

Countries

China

Contacts

Primary ContactXiangmin Xu, Prof. Dr.
xixm@smu.edu.cn(20) 61648293

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026